当前位置:首页 - 行情中心 - 辰欣药业(603367) - 财务分析 - 现金流量表

辰欣药业

(603367)

  

流通市值:105.17亿  总市值:105.17亿
流通股本:4.53亿   总股本:4.53亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,624,749,777.68703,053,747.483,425,737,841.942,656,152,737.21
  收到的税费返还--437,025.2275,818.85
  收到其他与经营活动有关的现金107,610,357.5342,518,547.68103,712,180.22118,013,443.95
  经营活动现金流入小计1,732,360,135.21745,572,295.163,529,887,047.362,774,442,000.01
  购买商品、接受劳务支付的现金398,995,042.23233,909,786.73811,199,696.44732,088,563.84
  支付给职工以及为职工支付的现金208,043,744.99108,584,238.38456,718,845.15326,001,774.64
  支付的各项税费158,283,398.49101,619,363.46390,417,317.1311,466,838.65
  支付其他与经营活动有关的现金613,682,062.06243,945,489.171,300,702,508.421,052,633,075.16
  经营活动现金流出小计1,379,004,247.77688,058,877.742,959,038,367.112,422,190,252.29
  经营活动产生的现金流量净额353,355,887.4457,513,417.42570,848,680.25352,251,747.72
二、投资活动产生的现金流量:
  取得投资收益收到的现金49,601,318.7928,536,327.6463,574,902.1844,840,675.43
  处置固定资产、无形资产和其他长期资产收回的现金净额1,888,5001,384,000486,50054,462
  收到的其他与投资活动有关的现金2,481,747,750.271,092,000,0001,840,599,5001,950,261,208.28
  投资活动现金流入小计2,533,237,569.061,121,920,327.641,904,660,902.181,995,156,345.71
  购建固定资产、无形资产和其他长期资产支付的现金56,315,581.8414,291,462.43101,806,190.571,589,435.05
  投资支付的现金--6,600,000-
  支付其他与投资活动有关的现金3,140,816,300.471,455,816,300.471,818,000,0002,359,370,780.71
  投资活动现金流出小计3,197,131,882.311,470,107,762.91,926,406,190.52,430,960,215.76
  投资活动产生的现金流量净额-663,894,313.25-348,187,435.26-21,745,288.32-435,803,870.05
三、筹资活动产生的现金流量:
  吸收投资收到的现金--1,000,000-
  其中:子公司吸收少数股东投资收到的现金--1,000,000-
  取得借款收到的现金15,344,8006,787,80053,325,00040,000,000
  收到其他与筹资活动有关的现金--26,865,899.0313,754,504.92
  筹资活动现金流入小计15,344,8006,787,80081,190,899.0353,754,504.92
  偿还债务支付的现金67,470,15067,000,000133,500,000132,500,000
  分配股利、利润或偿付利息支付的现金101,857,965.19160,435.16307,117,606.36203,137,176.87
  其中:子公司支付给少数股东的股利、利润--2,560,000-
  支付其他与筹资活动有关的现金867,141.34792,446.855,206,493.355,419,155.14
  筹资活动现金流出小计170,195,256.5367,952,882.01445,824,099.71341,056,332.01
  筹资活动产生的现金流量净额-154,850,456.53-61,165,082.01-364,633,200.68-287,301,827.09
四、汇率变动对现金及现金等价物的影响-243,672.26-39,683.25360,634.3-366,979.57
五、现金及现金等价物净增加额-465,632,554.6-351,878,783.1184,830,825.55-371,220,928.99
  加:期初现金及现金等价物余额1,120,473,303.891,120,473,303.89935,642,478.34935,642,478.34
  期末现金及现金等价物余额654,840,749.29768,594,520.791,120,473,303.89564,421,549.35
补充资料:
  净利润231,288,231.71-514,940,434.63-
  资产减值准备44,149,228.19-56,025,858.73-
  固定资产和投资性房地产折旧86,657,238.64-210,979,129.89-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧86,657,238.64-210,979,129.89-
  无形资产摊销4,675,759.69-9,900,425.68-
  长期待摊费用摊销231,789.41-2,093,281.41-
  处置固定资产、无形资产和其他长期资产的损失-419,694.25-139,530.24-
  固定资产报废损失0-630,555.03-
  公允价值变动损失-20,859,960.15--10,528,296.23-
  财务费用1,267,083.45-6,402,677.51-
  投资损失-34,665,215.33--62,304,296.38-
  递延所得税7,592,436.57-2,012,966.13-
  其中:递延所得税资产减少6,410,210.39-2,413,744.04-
    递延所得税负债增加1,182,226.18--400,777.91-
  存货的减少31,813,609.43--115,040,476.82-
  经营性应收项目的减少-28,004,246.65--20,822,679.74-
  经营性应付项目的增加-8,252,046.22-4,554,675.07-
  其他24,479,166.96--25,942,361.35-
  现金的期末余额654,840,749.29-1,120,473,303.89-
  减:现金的期初余额1,120,473,303.89-935,642,478.34-
  现金及现金等价物的净增加额-465,632,554.6-184,830,825.55-
公告日期2025-08-282025-04-222025-04-222024-10-29
审计意见(境内)标准无保留意见
TOP↑